curriculum vitae steven michael teutsch, m.d., m.p.h. curriculum vitae . steven michael teutsch,...

Download CURRICULUM VITAE STEVEN MICHAEL TEUTSCH, M.D., M.P.H. CURRICULUM VITAE . STEVEN MICHAEL TEUTSCH, M.D.,

Post on 24-Apr-2020

1 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

  • CURRICULUM VITAE STEVEN MICHAEL TEUTSCH, M.D., M.P.H. TRAINING AND EXPERIENCE:

    1954 - 1966 Primary and Secondary Education

    Salt Lake City, Utah

    1966 - 1970 Harvard College Cambridge, Massachusetts B.A., Biochemical Sciences Cum Laude 1970 - 1974 Duke University Medical School Durham, North Carolina M.D. 1972 - 1973 University of North Carolina School of Public Health Chapel Hill, North Carolina M.P.H., Epidemiology 1974 - 1977 Pennsylvania State University Hershey Medical Center Hershey, Pennsylvania Internship and Residency Internal Medicine

    1977 - 1979 Epidemic Intelligence Officer Parasitic Diseases Division Bureau of Epidemiology Centers for Disease Control

    Atlanta, Georgia 1979 - 1981 Chief, Kidney Disease Activity Center for Prevention Services Centers for Disease Control Atlanta, Georgia 1981 - 1983 Chief, Operational Research

    Division of Diabetes Control Center for Prevention Services Centers for Disease Control Atlanta, Georgia

    1983 - 1987 Chief, Technical and Operational Research Branch Division of Diabetes Control Center for Prevention Services Centers for Disease Control Atlanta, Georgia

  • 1987 - 1988 Chief, Epidemiologic Studies Branch

    Division of Surveillance and Epidemiologic Studies Epidemiology Program Office Centers for Disease Control Atlanta, Georgia

    1988 - 1991 Director, Division of Surveillance and Epidemiology

    Epidemiology Program Office Centers for Disease Control Atlanta, Georgia

    1991 - 1996 Special Assistant to the Director and

    Chief, Prevention Effectiveness Activity Epidemiology Program Office Centers for Disease Control and Prevention Atlanta, Georgia

    1996 - 1997 Director, Division of Prevention Research and Analytic Methods

    Epidemiology Program Office Centers for Disease Control and Prevention Atlanta, Georgia

    1997 - 1998 Senior Research Scientist Outcomes Research & Management Merck & Co., Inc. West Point, PA 1998 - 2007 Senior Director (Executive Director, 2001) Outcomes Research & Management Merck & Co., Inc. West Point, PA 2007 – 2008 Executive Director US Outcomes Research Merck & Co., Inc., West Point, PA

    2

  • 2009 -- 2014 Chief Science Officer Los Angeles County Department of Public Health

    Los Angeles, CA OTHER POSITIONS: 1980-1982 Member, National Center for Health Care Technology Technology Coordinating Committee End Stage Renal Disease Subcommittee

    1981-1983 Medical Advisory Board, Centers for Disease Control 1983 U.S. Public Health Service End Stage Renal Disease Coordinating Committee

    1983 Surgeon General's Conference on Organ Transplantation 1983 - 1984 Consultant to the Carter Center. Prepared diabetes section for Carter Center

    Closing the Gap Project. 1985 - 1986 Consultant to Carter Center Health Risk Appraisal Project 1985 - 1987 Consultant, National Office of Organ Transplantation 1986 - 1987 Surveillance Coordination Group, Chronic Disease Surveillance Subcommittee 1987 - 1989 National Kidney and Urologic Disease Advisory Board 1987 - 1989 National Kidney, Urologic, and Hematologic Diseases Interagency Coordinating

    Council 1988 - 1991 Chairman, Centers for Disease Control, Surveillance Coordination Group

    1988 - 1990 Member and initial author, workgroup on Data and Surveillance Systems, Year 2000 National Health Objectives

    1990 - 1997 Acting editor Morbidity and Mortality Weekly Report (in absence of editor)

    1992 - 1997 Chairman, Centers for Disease Control and Prevention, Prevention Effectiveness

    Technical Working Group,

    1993 - 1995 Member, Task Force on principles for Economic Analysis of Health Care Technology, Leonard Davis Institute, University of Pennsylvania

    1993 - 1995 CDC liaison to the US Preventive Services Task Force, Office of Disease

    Prevention and Health Promotion

    1993 - 1995 CDC liaison to the Panel on Cost Effectiveness in Health and Medicine, Office of Disease Prevention and Health Promotion

    1995 - 1996 Member, Advisory Committee, Center for Risk Analysis, Harvard School of

    Public Health 3

  • 1995 - 1997 Consultant to NIH Diabetes Prevention Program (Clinical Trial) 1996 Task Force on Technology Assessment of Medical Devices (Washington)

    1997 - 2001 Consultant to CDC Task Force on Community Preventive Services 1996 - 1997 Panel on Cost Effectiveness of Screening of Diabetes (CDC) 1998 - 2007 1998-2006 Member, US Preventive Services Task Force (chair methods work

    group) 2007 – Consultant, US Preventive Services Task Force

    1998 Member Workgroup on Noninfectious Diseases, Global disease Elimination and Eradication as Public Health Strategies

    2000-2001 Consultant, Robert Wood Johnson Foundation, Population Health and Scholars

    Program

    2000-2003 Member, Infectious Diseases Society of America, Practice Guideline Committee

    2000- Member, Guide to Community Preventive Services Task Force, CDC (Consultant after 2007)

    2001 – 2002 Member, Robert Wood Johnson Foundation Population Health Science and

    Policy Visiting and Technical Advisory Committees 2002-2003 Chair, expert panel on Risks and Benefits of Fish Consumption, Harvard Center

    for Risk Analysis

    2002-2003 Partnership to Promote Healthy Eating and Active Living. Economic Discovery Workshop, Physical Activity Working Group

    2000- Board Member, Partnership for Prevention (Council of Advisors, beginning 2009)

    2002-2003 Member, Medicare Advisory Committee. Partnership for Prevention 2001- Member, United Health Foundation State Health Rankings Scientific Advisory

    Group

    2003 - Member, National Commission on Prevention Priorities

    2003-2005 Member, Advisory Committee, Project MOVE, CDC

    2002-2005Member, Pennsylvania Cardiovascular Health Consortium

    2002 – 2009 Member, Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, CDC (chair methods subcommittee)

    2006 – 2011 Chair, Secretary’s Advisory Committee on Genetics, Health and Society

    (Member 2006-2008, Chair 2008-2011) 2006 Member, Technical Expert Panel, Objective-setting and Framework Process

    4

  • Healthy People 2020 2006 - 2008 Member, Personalized Health Care Work Group, American Health Information

    Community, Office of the National Coordinator for Health Information Technology, HHS

    2007 -2012 Member, Scientific Advisory Board, Evidence-Based Behavioral Practice 2008 - 2009 Member, Scientific Advisory Committee, National Pharmaceutical Council 2008 Member, Institute of Medicine Committee on State of the USA Health Indicators 2008 - Member, Medicare Evidence Development and Coverage Advisory Committee

    (MedCAC), Centers for Medicare and Medicaid Services, HHS 2009 - 2010 Priorities Subcommittee, Secretary’s Advisory Committee on Health Promotion

    and Disease Prevention (HP2020) 2009 -2013 Member, TRANSPERS, (Center for Translational and Policy Research on

    Personalized Medicine) Reimbursement and Policy Committee, UCSF 2009 - Member, Advisory Board, Center for Comparative Effectiveness of Genomic

    Medicine, University of Pennsylvania School of Medicine 2009- 2012 Member, External Stakeholder Advisory Group (ESAG), Center for

    Comparative Effectiveness Research in Cancer Genomics project (CANCERGEN), U Washington, SW Oncology Group, Center for Medical Technology Policy

    2010 Co-chair, Subcommittee of Secretary’s Advisory Committee on Health

    Promotion and Disease Prevention (HP2020) to recommend action steps and evidence to ensure the effective implementation of Healthy People 2020

    2010- 2014 Co-editor-in-Chief, Rx for Prevention (Los Angeles County Public Health

    Department newsletter for physicians) 2010- Chair Technical Advisory Committee, Adult, California Health Interview

    Survey.

    2010-2012 Member, Surveillance and Epidemiology Workgroup, Advisory Committee to the Director of CDC

    2010 – 2011 Member, Institute of Medicine Committee, Leading Health Indicators for Healthy People 2020

    2010-2012 Vice Chair, Committee on Public Health Strategies, Institute of Medicine

    2011 Leading Health Indicators Subcommittee, Secretary’s Advisory Committee on

    Health Promotion and Disease Prevention (HP2020)

    2011- 2014 Member, University of Southern California, Clinical Translational Science Institute (CTSI) Advisory Board

    5

  • 2011-2012 Member, Institute of Medicine, Committee on Valuing Community-Based, Non-

    Clinical Prevention Policies and Wellness Strategies 2011- Member, USPSTF-Scientific Resource Center Technical Expert Advisory Panel

    (TEAP) 2012- Member, Policy Committee, American College of Epidemiology 2012 Member, review panel on economic research in the National Center for

    Immunization and Respiratory Diseases (CDC) 2012 Chair, CDC review panel on PRISM (Prevention Impacts Simulation Model) 201

Recommended

View more >